Latest News

In this section you will find the latest Bayer Schering Pharma press releases for the United Kingdom.

If you have a particular enquiry about any of these releases then please contact us on the telephone number or e-mail address below:-

Tel: 01635 563198

E-mail: bsp-communications@bayerhealthcare.com

Bayer’s Novel Oral Anticoagulant Xarelto®(rivaroxaban) Gets European Licence

3rd October2008 

New drug Xarelto® (rivaroxaban), which has been shown to be significantly more effective than current standard, gets UK licence>>more

Bayer’s Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU

25th July 2008 

Venous blood clot prevention after elective hip or knee replacement surgery - Final approval from the European Commission expected within the next few months..>>more

Doctor in the House - TV’s Doctor Christian Jessen visits Bayer

18th June 2008 

TV celebrity, Dr. Christian Jessen, star of Channel 4’s ‘Embarrassing Illnesses’ and ‘Supersize vs Superskinny’ was at Bayer's Newbury headquarters this week to talk to staff about men's health issues.>>more

Rivaroxaban First Oral Anticoagulant to Show Superiority to Enoxaparin 30mg twice-daily in Preventing Blood Clots After Knee Replacement Surgery

30th May 2008 

New head-to-head Phase III data confirm oral anticoagulant rivaroxaban is significantly more effective than twice-daily injections ofenoxaparin in preventing life threatening blood clots after total knee replacement surgery.>>more

Font size
- 1 2 3 + Font size

click to adjust

Page tools
Search
. Advanced search







http://www.mslife.co.uk/scripts/pages/en/press/index.php

Copyright © Bayer Schering Pharma AG